Ensign Peak Advisors’s BioLife Solutions BLFS Stock Holding History

Ensign Peak Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,590	Closed	-$264K	–	1841
2022 Q3	$264K	Sell	11,590 -1,340	-10%	-$28.7K	﹤0.01%	1760
2022 Q2	$179K	Hold	12,930	–	–	﹤0.01%	1830
2022 Q1	$294K	Sell	12,930 -12,500	-49%	-$329K	﹤0.01%	1760
2021 Q4	$948K	Sell	25,430 -10,470	-29%	-$449K	﹤0.01%	1320
2021 Q3	$1.52M	Buy	35,900 +23,400	+187%	+$1.13M	﹤0.01%	1261
2021 Q2	$556K	Hold	12,500	–	–	﹤0.01%	1578
2021 Q1	$450K	Buy	+12,500	New	+$494K	﹤0.01%	1613

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ensign Peak Advisors's BLFS Position: Q4 2022 in Review

Ensign Peak Advisors sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 11,590 shares — an estimated $264K sold.

Ensign Peak Advisors first reported a position in BLFS in Q1 2021 and held it in 7 quarters. The position peaked at $1.52M in Q3 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

Ensign Peak Advisors reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 11,590 BioLife Solutions shares in Q4 2022, an estimated $264K.
Ensign Peak Advisors first reported a position in BioLife Solutions in Q1 2021 and held it in 7 quarters.
Ensign Peak Advisors's BioLife Solutions position peaked at $1.52M in Q3 2021.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.